Navigation Links
MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
Date:2/25/2008

CHARLOTTE, N.C., Feb. 25 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced that its senior management will give a presentation at the Raymond James 29th Annual Institutional Investors Conference held March 2-5 at the Hyatt Regency Grand Cypress in Orlando, Fla.

MedCath's senior management will give its presentation on Monday, March 3 at 8:05 am ET. The presentation will be web cast live over the Internet via MedCath's website (http://www.medcath.com) and will be available for 30 days.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates ten hospitals with a total of 663 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners manage the cardiovascular program at various hospitals and provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. MedCath Announces Venture With Two New Jersey Hospitals
2. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
3. MedCath Corporation Reports First Quarter Earnings
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
6. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
7. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
8. Meadowbrook Insurance Group, Inc. and ProCentury Corporation Reach Agreement to Merge in $272.6 Million Transaction
9. Nerites Corporation Announces Closing of Series A Funding Round
10. Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue
11. LodgeNet Interactive Corporation 2007 Earnings Release and Teleconference Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2008)...tic children whose parents have high expectations ...kely to have symptoms than other children dealing ...dren also are more likely to use asthma controller...for taking medicine and if their parents clearly u... The study, which appears in the Oct. 2008 issue o...
(Date:10/3/2008)...ding is beneficial. But can it help kids lose weig...terature on obese adolescents, researchers at Duke...ight type of novel may make a difference. , The ...who were already in a comprehensive weight loss pr... Rescue (Beacon Street Press). It was carefully cr...
(Date:10/3/2008)... Inc. Magazine recently included,Connolly Consulti...ng,private companies in the country. The list is t...egment of the economy -- America,s,independent-min...es,represent the backbone of the U.S. economy., (...3/NY36880LOGO ), Connolly Consulting,s consisten...
(Date:10/3/2008)...idents to Eat Right, Move More and ...t. 3 /PRNewswire/ -- The last decade can be define...hich seem to go in and out,of fashion like shoulde...en,slim. Two out of three Americans -- including 2...weight or obese., A new campaign crossing the cou...
Breaking Medicine News(10 mins):Health News:Children's asthma affected by parental expectations 2Health News:Duke researchers show reading can help obese kids lose weight 2Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Pennsylvania Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3
... disease that has spread in some villages of Banke...eks was diagnosed as cerebral malaria, The Himalay...y, advisor to the Health Ministry Mahesh Maskey sa...villages with essential equipment and medicines We...
...d tomatoes and infected food service workers are s... has sickened 171 people in 19 states. // DNA f...erotype Typhimurium as the cause of the outbreak a...Centers for Disease Control and Prevention (CDC), ...
...chnology savvy patients are experimenting with med...he online medium// to seek solutions to many of th...ke to hide in the closet. Thrush, ringworm and ur...he search list and back pain, stress and depressio...
...ng negative for the two inherited breast cancer ge...disease, suggests research published// ahead of pr...ld be regularly screened from 35 or 40 onwards, sa...h team assessed the families of 277 women in whom ...
Other Medicine News:Health News:Tomatoes: Culprits of Salmonella outbreak 2Health News:Women Testing Negative for Familial Breast Cancer Gene Still at Increased Risk 2
(Date:10/6/2008)...se 3b Studies with Durezol Dosed Prior to Surgery,...peutics, Inc., a,privately held ophthalmic-focused...urezol(TM) (difluprednate ophthalmic emulsion) 0.0...as approved by the U.S. Food and,Drug Administrati...eroid,indicated for the treatment of inflammation ...
(Date:10/6/2008)...lif. and SEATTLE, Oct. 6 /- Complete,...human genome sequencing,company, and the Institute...artnership to conduct populationwide human genome ...enomics will use its proprietary,DNA sequencing te...vided by,ISB. Then, once proof-of-concept has been...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/6/2008)...Other Product - Company,s Bioabsorbable Stent - Al...G, Oct. 6 /- Data from multiple clini... OrbusNeich,s Genous Bio-engineered R,stent, will ...vascular,Therapeutics symposium, TCT 2008, in Wash...the Academic Medical Center in,Amsterdam will prov...
Breaking Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 1Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 1685 8Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 1Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 2Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 15878 3Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 1Veterinary college researchers explore function of biofilm in bovine respiratory disease 2738 2Food for thought 2735 2/ 1
... Jun 09, 2007 (MARKET WIRE via COMTEX News Network...sidiary of Endo,Pharmaceuticals Holdings Inc. (NAS... randomized, double-blind, placebo-controlled,clin...e) 2.5 mg,tablets as a six-day preventative treatm...raine (MM). The data demonstrated,that FROVA signi...
...., June 11, 2007--New research supported by the,...of Arthritis and,Musculoskeletal and Skin Diseas...ion gabapentin , which is used for certain,type...he pain and,other symptoms associated with the c..., fibromyalgia. , In the NIAMS-sponsored, random...
Other Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Gabapentin Shown Effective for Fibromyalgia Pain 2Gabapentin Shown Effective for Fibromyalgia Pain 3
BiodivYsio stent with biocompatible coating (phosphorylcholine)
The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, s
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support.
Medicine Products: